Evidence map›Paper›PMID 24119294›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2013

HPV-related cancers after solid organ transplantation in the United States.

M M Madeleine, J L Finch, C F Lynch, M T Goodman, E A Engels

Open access · hybridAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 3 pooled it
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 3 syntheses or guidelines pooled it, 192 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Efficacy of Immune Checkpoint Inhibitors and Oncoviruses in Solid Tumors.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Review
  12. Article
  13. Evidence for Anal Dysplasia Treatment.Clinics in colon and rectal surgery · 2026
    Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 2 countries.

M M MadeleineProgram in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Epidemiology, University of Washington, Seattle, WA.
J L Finch
C F Lynch
M T Goodman
E A Engels
Cedars-Sinai Medical Center · USColorado Department of Public Health and Environment · USNational Cancer Institute · USUniversity of Iowa · USUniversity of Washington · US

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Douglas Robert Spitz · 2000 to 2026
$70.0M
NAT'L CANCER PREV & CONTROL PROG (COMPONENTS: MI COMPREH CANCER CONTR PROG, MI BRU58DP000812 · DP · MICHIGAN STATE DEPARTMENT OF HEALTH AND HUMAN SERVICES · PI BROOKOVER, PATRICIA · 2007 to 2011
$51.4M
NATIONAL CANCER PREVENTION AND CONTROL PROGRAMU58DP000824 · DP · TEXAS STATE DEPT OF HEALTH SERVICES · PI DELGADO, EVELYN · 2007 to 2011
$44.3M
Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Brandi Janssen · 1990 to 2026
$40.5M
COMPREHENSIVE CANCER CONTROL; OPTIONAL FUNDING (PROSTATE CANCER); ILLINOIS BREASTU58DP000805 · DP · ILLINOIS STATE DEPT OF PUBLIC HEALTH · PI SCHAFER, THOMAS J. · 2007 to 2011
$37.5M
THE GEORGIA COMPREHENSIVE CANCER PROGRAM TO REDUCE MORTALITYU58DP000817 · DP · GEORGIA STATE DEPT OF HUMAN RESOURCES · PI REDDING, KIMBERLY · 2007 to 2011
$27.1M
Category A - Communities Putting Prevention to WorkU58DP000848 · DP · COLORADO STATE DEPT/PUB HLTH & ENVIRONMT · PI JACOBELLIS, JILLIAN · 2007 to 2011
$25.9M
Infections, immunity, and inflammation in cancerZIACP010150 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ENGELS, ERIC A · 2009 to 2025
$24.0M
NATIONAL CANCER PREVENTION AND CONTROL PROGRAMU58DP000832 · DP · NC STATE DEPT/HLTH & HUMAN SERVICES · PI PETERSEN, RUTH · 2007 to 2011
$23.6M
CALIFORNIA'S PARTICIPATION IN THE NATIONAL CANCER PREVENTION AND CONTRO PROGRAMU58DP000807 · DP · PUBLIC HEALTH INSTITUTE · PI SNIPES, KURT P · 2007 to 2011
$22.5M
NPCR-ENHANCEMENT OF EXISTING CANCER REGISTRY NBCCEDP-PROVIDE BREAST $ CERVICAL CAU58DP000808 · DP · NEW JERSEY STATE DEPT/HEALTH/SENIOR SRVS · PI RODRIGUEZ, GLORIA · 2007 to 2011
$21.1M
VIROLOGIC/GENETIC FACTORS OF HPV NEOPLASMSP01CA042792 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MADELEINE, MARGARET M · 1987 to 2011
$21.0M
Intramural NIH HHSNCCDPHP CDC HHS 1U58 DP000807-01NCCDPHP CDC HHS 5658DP000805-04NCCDPHP CDC HHS 5U58/DP000808-05NCCDPHP CDC HHS 5U58DP000812-03NCCDPHP CDC HHS 5U58DP000817-05NCCDPHP CDC HHS 5U58DP000824-04NCCDPHP CDC HHS U58 DP000805NCCDPHP CDC HHS U58 DP000807NCCDPHP CDC HHS U58 DP000808NCCDPHP CDC HHS U58 DP000812NCCDPHP CDC HHS U58 DP000817NCCDPHP CDC HHS U58 DP000824NCCDPHP CDC HHS U58 DP000832NCCDPHP CDC HHS U58DP000832NCCDPHP CDC HHS U58 DP000848NCCDPHP CDC HHS U58 DP000848-04NCCDPHP CDC HHS U58DP0038789NCI NIH HHS HHSN261201000024CNCI NIH HHS HHSN261201000026CNCI NIH HHS HHSN261201000027CNCI NIH HHS HHSN261201000034CNCI NIH HHS HHSN261201000035CNCI NIH HHS HHSN261201000035INCI NIH HHS HHSN261201000036CNCI NIH HHS HHSN261201000037CNCI NIH HHS N01 PC035137NCI NIH HHS N01 PC035139NCI NIH HHS N01 PC035142NCI NIH HHS N01 PC035143NCI NIH HHS N01 PC054405NCI NIH HHS N01-PC-35137NCI NIH HHS N01-PC-35139NCI NIH HHS N01-PC-35142NCI NIH HHS N01-PC-35143NCI NIH HHS N01-PC-54405NCI NIH HHS P01 CA042792NIEHS NIH HHS P30 ES005605
6 · The paper itself

Abstract

Transplant recipients have elevated cancer risk including risk of human papillomavirus (HPV)-associated cancers of the cervix, anus, penis, vagina, vulva and oropharynx. We examined the incidence of HPV-related cancers in 187 649 US recipients in the Transplant Cancer Match Study. Standardized incidence ratios (SIRs) compared incidence rates to the general population, and incidence rate ratios (IRRs) compared rates across transplant subgroups. We observed elevated incidence of HPV-related cancers (SIRs: in situ 3.3-20.3, invasive 2.2-7.3), except for invasive cervical cancer (SIR 1.0). Incidence increased with time since transplant for vulvar, anal and penile cancers (IRRs 2.1-4.6 for 5+ vs. <2 years). Immunophenotype, characterized by decreased incidence with HLA DRB1:13 and increased incidence with B:44, contributed to susceptibility at several sites. Use of specific immunosuppressive medications was variably associated with incidence; for example, tacrolimus, was associated with reduced incidence for some anogenital cancers (IRRs 0.4-0.7) but increased incidence of oropharyngeal cancer (IRR 2.1). Thus, specific features associated with recipient characteristics, transplanted organs and medications are associated with incidence of HPV-related cancers after transplant. The absence of increased incidence of invasive cervical cancer highlights the success of cervical screening in this population and suggests a need for screening for other HPV-related cancers.

Indexed as

AdolescentAdultAnus NeoplasmsCohort StudiesFemaleHumansImmunosuppression TherapyIncidenceMaleMiddle AgedOrgan TransplantationOropharyngeal NeoplasmsPapillomavirus InfectionsPenile NeoplasmsRegistriesTacrolimusTacrolimusHPV-related cancerimmunosuppressionorgan transplant cohortTransplant Cancer Match Study

Identifiers

PMID24119294
PMCPMC4049182
OpenAlexW1894863068

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.